| Abbreviation | Definition |
| Aβ | amyloid-β |
| AD | Alzheimer’s disease |
| ADME | absorption, distribution, metabolism, and excretion |
| AFM | atomic force microscopy |
| ALS | amyotrophic lateral sclerosis |
| ARIA | amyloid-related imaging abnormalities |
| BBB | blood–brain barrier |
| CD | circular dichroism |
| CNS | central nervous system |
| CNT | carbon nanotube |
| DAM | disease-associated microglia |
| DLS | dynamic light scattering |
| EAE | experimental autoimmune encephalomyelitis |
| FDA | U.S. Food and Drug Administration |
| FT-IR | Fourier-transform infrared spectroscopy |
| GO | graphene oxide |
| GQD | graphene quantum dot |
| HD | Huntington’s disease |
| hIAPP | human islet amyloid polypeptide |
| HR-TEM | high resolution transmission electron microscopy |
| IL-1β | interleukin-1β |
| MAPK | mitogen-activated protein kinase |
| MRI | magnetic resonance imaging |
| NF-κB | nuclear factor κB |
| NLRP3 | NLR family pyrin domain-containing 3 |
| NPC | Niemann-Pick type C |
| PD | Parkinson’s disease |
| PET | positron emission tomography |
| PI | propidium iodide |
| QD | quantum dot |
| QD-LED | quantum dot light-emitting diode |
| RGDS | arginine-glycine-aspartate-serine peptide |
| ROS | reactive oxygen species |
| SPR | surface plasmon resonance |
| TDP-43 | TAR DNA-binding protein 43 |
| TEM | transmission electron microscopy |
| WST-1 | water-soluble tetrazolium salt-1 |
| XPS | X-ray photoelectron spectroscopy |